<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is renewed interest in flexible sigmoidoscopy (FS) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) screening following trials showing significantly reduced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> incidence and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To evaluate the potential usefulness of FS screening in our population </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We examined rectosigmoid (RS) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> epidemiology in our Jewish population using Israel National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry data, computed by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> site, age groups, and gender </plain></SENT>
<SENT sid="3" pm="."><plain>We also reviewed endoscopy-screening publications for prevalence of RS and proximal advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> (AAP) and having both or either </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During 1980-2008, there were 64,559 CRCs registered; 31.6 % were RS <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> which has now decreased to 29 % of men's and 26 % of women's <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (both P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>In &lt;50 year olds, RS <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> occurred in 42 % of males' and 35 % of females' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and in the last 2 decades this ratio is unchanged </plain></SENT>
<SENT sid="6" pm="."><plain>In 50-74 year olds, RS <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> decreased to stable levels of 32 % of males' and 29 % females' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (both P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>In â‰¥75 year olds, RS <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> progressively decreased to 24 % of males' and 22 % females' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (both P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>From endoscopy screening reports in 40-79 year olds, RS AAPs occurred in 2.0-5.8 %, being least in women, most in men, and not increased with aging </plain></SENT>
<SENT sid="9" pm="."><plain>Some 50-57 % of screenees had both RS and proximal AAPs, least when aged 40-49 years at 25 %, women were 35 %, and with aging 40 %, but most in men at 70 % </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: With the changing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> epidemiology, having fewer RS <z:hpo ids='HP_0002664'>neoplasms</z:hpo> but more proximal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, the effectiveness of FS screening for identifying significant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> decreases with screenees' age and especially in females </plain></SENT>
<SENT sid="11" pm="."><plain>These make FS screening less suitable for our aging and increasingly female population </plain></SENT>
</text></document>